MedTrace Logo

Effects of Avenanthramide-enriched Oats on Inflammation

NCT01527604 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2014-11-19

No results posted yet for this study

Summary

The objective of this randomized, double-blinded, placebo-controlled, parallel trial is to determine whether consuming avenanthramide-enriched oats daily for 8 weeks on can improve biomarkers of inflammation in older, obese adults.

Conditions

Interventions

OTHER

Avenanthramide-enriched oats

avenanthramide-enriched oats, delivered as muffins at a dose of 2 muffins per day for 56 days.

OTHER

Refined flour absent avenanthramides

refined flour absent avenanthramides, delivered as muffins at a dose of 2 muffins per day for 56 days.

Sponsors & Collaborators

  • Agriculture and Agri-Food Canada

    collaborator OTHER_GOV

  • Tufts University

    lead OTHER

Principal Investigators

  • Diane L. McKay, PhD · Tufts Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01527604 on ClinicalTrials.gov